We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
DIAPH2 gene polymorphisms and laryngeal cancer risk in men.
- Authors
Cichocka, Edyta; Górczyńska-Kosiorz, Sylwia; Misiołek, Maciej; Ścierski, Wojciech; Koniewska, Anna; Stryjewska-Makuch, Grażyna; Gumprecht, Janusz
- Abstract
Background: The DIAPH2 gene is one of the genes commonly associated with laryngeal squamous cell carcinoma (LSCC). In our study, we considered the four polymorphisms of this gene, i.e. rs5920828, rs4322175, rs12851931 and rs5921830 as potential genetic risk factors for LSCC. Methods: We determined the genotyping of the genetic variants of DIAPH2 in 230 male patients with histologically confirmed LSCC compared to the European population. Demographic and environmental exposure data of each subject were examined. To conduct the genetic tests, extraction of total DNA was performed. We genotyped all four variants in each patient and determined their frequencies. Results: In the case of the rs12851931 polymorphism in the DIAPH2 gene, a significant difference was observed in the distribution of the T stage depending on the polymorphism. Heterozygotes were more often associated with T2 stage, while homozygotes were more likely to have higher tumor stages. The rs12851931 homozygotes of DIAPH2 were statistically significantly more prevalent in smokers. The results suggested that rs12851931 polymorphism in DIAPH2 could increase the onset risk of LSCC. Conclusions: Our results provide further information on the role of the DIAPH2 gene in the pathogenesis of LSCC.
- Publication
Journal of Cancer Research & Clinical Oncology, 2024, Vol 150, Issue 6, p1
- ISSN
0171-5216
- Publication type
Article
- DOI
10.1007/s00432-024-05820-4